Circulating miRNA95 and miRNA190 Are Sensitive Markers for the Differential Diagnosis of Thyroid Nodules in a Caucasian Population
Silvia Cantara(University of Siena), Furio Pacini(University of Siena), Guido Sebastiani(University of Siena), Tania Pilli(University of Siena), Giulia Busonero(University of Siena), Sandro Cardinale(University of Siena), Francesco Dotta(University of Chieti-Pescara), Gabriele Cevenini(University of Siena)
Cited by 56
Related Papers
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
|The Lancet|2017|843
Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial
|Diabetes Care|2017|574
A Comparison of Recombinant Human Thyrotropin and Thyroid Hormone Withdrawal for the Detection of Thyroid Remnant or Cancer1
|The Journal of Clinical Endocrinology & Metabolism|1999|564
Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 Trial
|Diabetes Care|2019|442
Impact of Proto-Oncogene Mutation Detection in Cytological Specimens from Thyroid Nodules Improves the Diagnostic Accuracy of Cytology
|The Journal of Clinical Endocrinology & Metabolism|2010|316